Clinical Trials Logo
  1. Home
  2. Severe Obesity
  3. NCT02710786
  4. Details
NCT02710786 Clinical Trial

Comorbidity After Gastric Bypass

Severe Obesity Clinical Trial

Official title:
Long-term Resolution of Comorbidites After Gastric Bypass

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02710786
Other study ID # Comorb
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 2007
Est. completion date January 2025

Study information
Verified date December 2023
Source Uppsala University
Contact Erik Näslund
Email erik.naslund@ki.se
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To evaluate effect on comorbid disease and weight loss in the long-term (>five years) after Roux-en-Y gastric bypass (RYGB) surgery for severe obesity.

Description:

Individuals with severe obesity frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss in the long-term (10 years) after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.

Recruitment information / eligibility
Status Recruiting
Enrollment 25000
Est. completion date January 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Registered individuals in Scandinavian Obesity Surgery Registry (SOReg) having had gastric bypass Exclusion Criteria: - All other operations

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Gastric bypass
Gastric bypass surgery, i.e., small gastric pouch and excluded main stomach

Locations
Country Name City State
Sweden Uppsala University Uppsala

Sponsors (3)
Lead Sponsor Collaborator
Uppsala University Karolinska Institutet, The Scandinavian Obesity Surgery Registry

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in comorbid conditions, as defined by use of pharmacological treatment Remission of diabetes mellitus, hypertension, dyslipidemia, and depression as defined by use of pharmacological treatment, and sleep apnea as defined by use of CPAP. Data will be collected from SOReg. 10 years
Secondary Number of patients with pathological laboratory data (corresponding to the studied comorbid conditions) Glucose, HbA1c, LDL, HDL, triglycerides, and blood pressure 10 years
Secondary Weight loss Peroperative weight (in kg) minus current weight (in kg) 10 years
Secondary BMI loss Peroperative BMI minus current BMI. Weight and height will be combined to report BMI in kg/m^2. 10 years
See also
  Status Clinical Trial Phase
Completed NCT03690752 - Adherence to Walking on an Alter G Anti-Gravity Treadmill N/A
Active, not recruiting NCT02767505 - Bypass Equipoise Sleeve Trial (BEST) N/A
Recruiting NCT05786092 - Impact of Telemonitoring on Metabolic Variables in Severe Obesity N/A
Active, not recruiting NCT03249441 - Compassion-Focused Therapy for People With Severe Obesity. N/A
Terminated NCT04626232 - Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients N/A
Completed NCT02952963 - Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass Phase 4
Active, not recruiting NCT02374632 - Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass Phase 4
Active, not recruiting NCT04165694 - Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision N/A
Not yet recruiting NCT06162715 - GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial Phase 2
Completed NCT05409612 - Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients Phase 3
Completed NCT03638895 - Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service N/A
Not yet recruiting NCT05493592 - Pigeon Peas (Cajanus Cajan) : a Natural Anti-inflammatory Facilitating Weight Loss in Obese Patients Returning to Sport? N/A
Completed NCT02823561 - Garcinia Mangostana Extracts in the Management of Weight Loss Phase 4
Completed NCT02340247 - Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass Phase 4
Recruiting NCT02076880 - SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients N/A
Completed NCT04042493 - Connect for Health Pediatric Weight Management Program N/A
Completed NCT04129801 - Muscle Strength in Severe Obese Patients in the Postoperative of Bariatric Surgery
Completed NCT05341414 - Trajectories of Resilience and Bariatric Surgery Outcomes
Recruiting NCT02409160 - Sleep and Immune Response in Severe Obese Patients Undergoing Bariatric Surgery. N/A
Completed NCT00623792 - Study on Impact of Lifestyle Change and Weight Loss Before Bariatric Surgery N/A